Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient Safety”

30,931 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30,931 results

Not applicableStudy completedNCT04041700
What this trial is testing

Clinical Performance, Safety and Patient Reported Outcomes of an Active Osseointegrated Steady-State Implant System

Who this might be right for
Hearing Loss
Cochlear 29
Testing effectiveness (Phase 2)Temporarily pausedNCT03097107
What this trial is testing

Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL

Who this might be right for
Dyslipidemias
Zydus Therapeutics Inc. 124
Testing effectiveness (Phase 2)Looking for participantsNCT07002034
What this trial is testing

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Who this might be right for
Adjustment Disorder
Reunion Neuroscience Inc 100
Testing effectiveness (Phase 2)Study completedNCT01936532
What this trial is testing

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)

Who this might be right for
Newly Diagnosed Multiple Myeloma
Nantes University Hospital 42
Post-approval studies (Phase 4)Study completedNCT02049606
What this trial is testing

To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee

Who this might be right for
Osteoarthritis of the Knee
PMG Pharm Co., Ltd 134
Early research (Phase 1)Study completedNCT05321147
What this trial is testing

Safety and Efficacy of Lacutamab in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma That Express KIR3DL2

Who this might be right for
Peripheral T Cell Lymphoma
Innate Pharma 20
Large-scale testing (Phase 3)Study completedNCT00637949
What this trial is testing

Safety of Lumiracoxib in Patients With Osteoarthritis

Who this might be right for
Osteoarthritis
Novartis 309
Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Large-scale testing (Phase 3)Study completedNCT03216226
What this trial is testing

A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus

Who this might be right for
HypoglycemiaDiabetes Mellitus, Type 1
Zealand Pharma 112
Large-scale testing (Phase 3)Ended earlyNCT01252355
What this trial is testing

Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta

Who this might be right for
Multiple Sclerosis Relapse
Sanofi 534
Post-approval studies (Phase 4)Looking for participantsNCT05955326
What this trial is testing

Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

Who this might be right for
Acute Cerebral Ischemia
Pharmazz, Inc. 160
Testing effectiveness (Phase 2)Study completedNCT06259526
What this trial is testing

The Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression

Who this might be right for
Depression
Tasly Pharmaceutical Group Co., Ltd 267
Early research (Phase 1)Study completedNCT00569985
What this trial is testing

Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890585
What this trial is testing

Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL

Who this might be right for
BTK InhibitorsHistone Deacetylase InhibitorDouble Express Diffuse Large B-cell Lymphoma
Li Zhiming 128
Large-scale testing (Phase 3)Study completedNCT02813785
What this trial is testing

Atezolizumab Compared With Docetaxel in Non-Small Cell Lung Cancer (NSCLC) After Failure With Platinum-Containing Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 565
Testing effectiveness (Phase 2)Ended earlyNCT00417885
What this trial is testing

A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 6
Testing effectiveness (Phase 2)Study completedNCT01591044
What this trial is testing

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Who this might be right for
Asthma
Rigel Pharmaceuticals 301
Early research (Phase 1)Ended earlyNCT02315144
What this trial is testing

An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease
Teva Branded Pharmaceutical Products R&D, Inc. 61
Testing effectiveness (Phase 2)Ended earlyNCT04776044
What this trial is testing

Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19

Who this might be right for
COVID-19
Atriva Therapeutics GmbH 133
Post-approval studies (Phase 4)UnknownNCT05075044
What this trial is testing

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected

Who this might be right for
HIV InfectionsCOVID-19
China National Biotec Group Company Limited 400
Load More Results